Saccadic impairment in schizophrenia with prominent negative symptoms

被引:5
|
作者
Gurvich, Caroline T. [1 ,2 ,4 ]
Fitzgerald, Paul B. [4 ]
Georgiou-Karistianis, Nellie [1 ]
White, Owen B. [2 ,3 ]
机构
[1] Monash Univ, Sch Psychol Psychiat & Psychol Med, Expt Neuropsychol Res Unit, Clayton, Vic, Australia
[2] Royal Melbourne Hosp, Brain Syst Res Lab, Mental Hlth Res Inst, Parkville, Vic 3050, Australia
[3] Royal Melbourne Hosp, Parkville, Vic 3050, Australia
[4] Monash Univ, Sch Psychol Psychiat & Psychol Med, Monash Alfred Psychiat Res Ctr, Alfred Hosp, Prahran, Vic 3004, Australia
关键词
negative symptoms; response variability; saccades; schizophrenia;
D O I
10.1097/WNR.0b013e32830e4622
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Motor disturbances are frequently reported in schizophrenia, particularly in association with negative symptoms, and may reflect frontostriatal dysfunction. This study investigated the timing of self-paced and reprogrammed saccades in 21 patients with schizophrenia, 11 with and 10 without prominent negative symptoms, as compared with 14 healthy controls. Results indicated that schizophrenia patients with increased negative symptoms scores had increased intraindividual variability in their timing of self-paced and reprogrammed saccades and performed saccades with increased peak velocities. It is possible that increased variability may reflect frontostriatal impairments and increased peak velocity may reflect serotonin changes or prefrontal cortex dysfunction. NeuroReport 19:1435-1439 (C) 2008 Wolters Kluwer Health \ Lippincott Williams & Wilkins.
引用
收藏
页码:1435 / 1439
页数:5
相关论文
共 50 条
  • [31] Antipsychotic drugs for patients with schizophrenia and predominant or prominent negative symptoms: a systematic review and meta-analysis
    Krause, Marc
    Zhu, Yikang
    Huhn, Maximilian
    Schneider-Thoma, Johannes
    Bighelli, Irene
    Nikolakopoulou, Adriani
    Leucht, Stefan
    EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE, 2018, 268 (07) : 625 - 639
  • [32] Olanzapine versus risperidone:: Results of a one year randomized trial in outpatients with schizophrenia with prominent negative symptoms
    Ciudad, A
    Alvarez, E
    Bousoño, M
    Cuesta, M
    Gómez, JC
    Olivares, JM
    SCHIZOPHRENIA RESEARCH, 2004, 67 (01) : 161 - 162
  • [33] Pomaglumetad methionil: No significant difference as an adjunctive treatment for patients with prominent negative symptoms of schizophrenia compared to placebo
    Stauffer, Virginia L.
    Millen, Brian A.
    Andersen, Scott
    Kinon, Bruce J.
    LaGrandeur, Lisa
    Lindenmayer, J. P.
    Gomez, Juan Carlos
    SCHIZOPHRENIA RESEARCH, 2013, 150 (2-3) : 434 - 441
  • [34] Viral metagenomics in drug-naive, first-onset schizophrenia patients with prominent negative symptoms
    Canuti, Marta
    van Beveren, Nico J. M.
    Farsani, Seyed Mohammad Jazaeri
    de Vries, Michel
    Deijs, Martin
    Jebbink, Maarten F.
    Zaaijer, Hans L.
    van Schaik, Barbera D. C.
    van Kampen, Antoine H. C.
    van der Kuyl, Antoinette C.
    de Haan, Lieuwe
    Storosum, Jitschak G.
    van der Hoek, Lia
    PSYCHIATRY RESEARCH, 2015, 229 (03) : 678 - 684
  • [35] Responses to antipsychotic therapy among patients with schizophrenia or schizoaffective disorder and either predominant or prominent negative symptoms
    Stauffer, Virginia L.
    Song, Guochen
    Kinon, Bruce J.
    Ascher-Svanum, Haya
    Chen, Lei
    Feldman, Peter D.
    Conley, Robert R.
    SCHIZOPHRENIA RESEARCH, 2012, 134 (2-3) : 195 - 201
  • [36] The network characteristics in schizophrenia with prominent negative symptoms: a multimodal fusion study (vol 10, 10, 2024)
    Kong, Li
    Zhang, Yao
    Wu, Xu-ming
    Wang, Xiao-xiao
    Wu, Hai-su
    Li, Shuai-biao
    Chu, Min-yi
    Wang, Yi
    Lui, Simon S. Y.
    Lv, Qin-yu
    Yi, Zheng-hui
    Chan, Raymond C. K.
    SCHIZOPHRENIA, 2024, 10 (01)
  • [37] Optimal cutoff scores of the Chinese version of 15-item negative symptom assessment that indicate prominent negative symptoms of schizophrenia
    Zhou, Qi
    Pu, Cheng-cheng
    Huang, Bing-jie
    Miao, Qi
    Zhou, Tian-hang
    Cheng, Zhang
    Gao, Tian-Qi
    Shi, Chuan
    Yu, Xin
    FRONTIERS IN PSYCHIATRY, 2023, 14
  • [38] Negative symptoms and cognitive impairment are associated with distinct motivational deficits in treatment resistant schizophrenia
    Saleh, Y.
    Jarratt-Barnham, I.
    Petitet, P.
    Fernandez-Egea, E.
    Manohar, S. G.
    Husain, M.
    MOLECULAR PSYCHIATRY, 2023, 28 (11) : 4831 - 4841
  • [39] Cognitive impairment and enduring negative symptoms: A comparative study of geriatric and nongeriatric schizophrenia patients
    Putnam, KM
    Harvey, PD
    SCHIZOPHRENIA BULLETIN, 2000, 26 (04) : 867 - 878
  • [40] Cognitive impairment and substance abuse history as predictors of the temporal stability of negative symptoms in schizophrenia
    Lysaker, PH
    Bell, MD
    Bioty, SM
    Zito, WS
    JOURNAL OF NERVOUS AND MENTAL DISEASE, 1997, 185 (01) : 21 - 26